13F filer · CIK 1318153
Mayo Clinic
Rochester, MN · filing since Q4 2019 · last filing Nov 12, 2024
Reported value
$2.9M
$-127.8K vs prior
Positions
3
New / sold out
0 / 1
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $190.1K
Top-10 weight
100.0%
Biggest buys vs Q2 2024
No new or increased positions this quarter.
Biggest sells vs Q2 2024
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | Neuroone Medical Technologies | -181,754 | -100.0% | $-145.4K |
| Reduced | Zentalis Pharmaceuticals Inc | -12,143 | -6.5% | $-44.7K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2024
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ISHARES TRMSCI ACWI ETF | 17,359 | $2.1M | 71.52% |
| 2 | Zentalis Pharmaceuticals IncCOMMON | 175,000 | $644.0K | 22.19% |
| 3 | UNITY BIOTECHNOLOGY INCCOMMON | 124,081 | $182.4K | 6.29% |